Do you want to read an article? Please log in or register.
The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region
COVID-19
Related content
COVID-19
Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement
CA Cancer J Clin.
Lenihan D, Carver J, Porter C, Liu JE, Dent S, Thavendiranathan P, Mitchell JD, Nohria A, Fradley MG, Pusic I, Stockerl-Goldstein K, Blaes A, Lyon AR, Ganatra S, López-Fernández T, O'Quinn R, Minotti G, Szmit S, Cardinale D, Alvarez-Cardona J, Curigliano G, Neilan TG, Herrmann J
doi: 10.3322/caac.21635.
COVID-19
Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic
Eur J Cancer.
Indini A, Rijavec E, Ghidini M, Cattaneo M, Grossi F
doi: 10.1016/j.ejca.2020.05.017.
COVID-19
Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it!
Eur J Cancer.
Omarini C, Maur M, Luppi G, Narni F, Luppi M, Dominici M, Longo G, Piacentini F
doi: 10.1016/j.ejca.2020.04.034.
Further PublicationsCOVID-19
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
Eur J Cancer.
Lièvre A, Turpin A, Ray-Coquard I, Le Malicot K, Thariat J, Ahle G, Neuzillet C, Paoletti X, Bouché O, Aldabbagh K, Michel P, Debieuvre D, Canellas A, Wislez M, Laurent L, Mabro M, Colle R, Hardy-Bessard AC, Mansi L, Colomba E, Bourhis J, Gorphe P, Pointreau Y, Idbaih A, Ursu R, Di Stefano AL, Zalcman G, Aparicio T, GCO-002 CACOVID-19 collaborators/investigators.
doi: 10.1016/j.ejca.2020.09.035.
COVID-19
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
Eur J Cancer
Lièvre A, Turpin A, Ray-Coquard I, Le Malicot K, Thariat J, Ahle G, Neuzillet C, Paoletti X, Bouché O, Aldabbagh K, Michel P, Debieuvre D, Canellas A, Wislez M, Laurent L, Mabro M, Colle R, Hardy-Bessard AC, Mansi L, Colomba E, Bourhis J, Gorphe P, Pointreau Y, Idbaih A, Ursu R, Di Stefano AL, Zalcman G, Aparicio T, GCO-002 CACOVID-19 collaborators/investigators.
doi: 10.1016/j.ejca.2020.09.035
Genitourinary CancerCOVID-19
Lessons from the coronavirus disease 2019 pandemic: Will virtual patient management reshape uro-oncology in Germany?
Eur J Cancer.
Rodler S, Apfelbeck M, Stief C, Heinemann V, Casuscelli J
doi: 10.1016/j.ejca.2020.04.003.
Further Publications
Immunological features of coronavirus disease 2019 in patients with cancer
Eur J Cancer.
Thibaudin M, Fumet JD, Bon M, Hampe L, Limagne E, Ghiringhelli F
doi: 10.1016/j.ejca.2020.08.013.
COVID-19
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer
Eur J Cancer.
Angelis V, Tippu Z, Joshi K, Reis S, Gronthoud F, Fribbens C, Okines A, Stanway S, Cottier E, McGrath S, Watkins D, Noble J, Bhosle J, Gerlinger M, Hamid I, Soliman H, Nenclares P, Jones R, Harrington K, Gennatas S
doi: 10.1016/j.ejca.2020.06.027.
RECOMMENDED
COVID-19
Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey
★ 1
Recommended by
Prof. Dr Stephan Bodis, Faculty Member
doi: 10.1016/j.ejca.2020.03.024.